{
  "case_summary": {
    "name": "Radiant Point Aesthetics, LLC",
    "location": "Austin, TX",
    "footprint": "6 treatment rooms; 2 injectors (MD+NP), 1 laser tech, 2 estheticians",
    "service_mix": {
      "injectables": 0.72,
      "laser_devices": 0.13,
      "facials_peels": 0.1,
      "retail": 0.05
    }
  },
  "ttm_metrics": {
    "ttm_revenue": 7040000,
    "ttm_product_cogs": 1020800,
    "ttm_provider_cogs": 739200,
    "ttm_gross_profit": 5280000,
    "ttm_rent": 312000,
    "ttm_marketing": 492800,
    "ttm_admin_salaries": 1800000,
    "ttm_other_opex": 844800,
    "ttm_onetime": 40000,
    "ttm_ebitda_reported": 1790900,
    "ttm_ebitda_adjusted": 1982900,
    "gross_margin": 0.75,
    "ebitda_margin_reported": 0.25438920454545455,
    "ebitda_margin_adjusted": 0.28166193181818183
  },
  "ebitda_bridge": {
    "reported_ebitda": 1790900,
    "owner_salary_addback": 120000,
    "emr_onetime_addback": 80000,
    "legal_onetime_addback": 40000,
    "rent_normalization": -48000,
    "adjusted_ebitda": 1982900
  },
  "valuation_matrix": {
    "7.0x": {
      "multiple": 7.0,
      "enterprise_value": 13880300.0,
      "equity_value": 13045300.0,
      "ev_revenue_implied": 1.9716335227272728
    },
    "7.5x": {
      "multiple": 7.5,
      "enterprise_value": 14871750.0,
      "equity_value": 14036750.0,
      "ev_revenue_implied": 2.1124644886363635
    },
    "8.0x": {
      "multiple": 8.0,
      "enterprise_value": 15863200.0,
      "equity_value": 15028200.0,
      "ev_revenue_implied": 2.2532954545454547
    },
    "8.5x": {
      "multiple": 8.5,
      "enterprise_value": 16854650.0,
      "equity_value": 16019650.0,
      "ev_revenue_implied": 2.3941264204545454
    },
    "9.0x": {
      "multiple": 9.0,
      "enterprise_value": 17846100.0,
      "equity_value": 17011100.0,
      "ev_revenue_implied": 2.5349573863636365
    },
    "9.5x": {
      "multiple": 9.5,
      "enterprise_value": 18837550.0,
      "equity_value": 18002550.0,
      "ev_revenue_implied": 2.6757883522727273
    },
    "10.0x": {
      "multiple": 10.0,
      "enterprise_value": 19829000.0,
      "equity_value": 18994000.0,
      "ev_revenue_implied": 2.816619318181818
    }
  },
  "irr_analysis": {
    "entry_ev": 16854650.0,
    "entry_equity": 16019650.0,
    "debt_amount": 12219621.25,
    "year5_revenue": 10344069.660672003,
    "year5_ebitda": 3016971.3400934413,
    "exit_ev": 24135770.72074753,
    "exit_equity": 24135770.72074753,
    "irr": 0.08542952228135547,
    "mom_multiple": 1.5066353335277318,
    "hold_period": 5
  },
  "epv_results": {
    "ebit": 1922900,
    "nopat": 1442175.0,
    "reinvestment": 192290.0,
    "fcf": 1249885.0,
    "epv_enterprise": 10415708.333333334,
    "epv_equity": 9580708.333333334,
    "epv_vs_multiple_ev": 0.6179723894197349,
    "implied_multiple": 5.252765310067746
  },
  "risk_analysis": {
    "key_risks": [
      "Single-clinician dependency (MD + NP injector model)",
      "Related-party lease re-pricing risk at renewal",
      "Injector hiring pipeline and retention challenges",
      "Market saturation in Austin injectables market",
      "Regulatory changes affecting aesthetic procedures",
      "Economic sensitivity of discretionary spending"
    ],
    "mitigants": [
      "Strong referral flywheel and 24k active patient base",
      "Diversified service mix beyond just injectables",
      "Proven ability to scale (added NP in Q3-24)",
      "Strong operational metrics (84% room utilization)",
      "Established EMR and online booking systems",
      "Cash-pay model reduces payor concentration risk"
    ],
    "value_drivers": [
      "Room utilization expansion potential (current 84%)",
      "Average ticket growth ($540 to $560 achieved)",
      "Service mix optimization opportunities",
      "Operational leverage on fixed cost base",
      "Geographic expansion potential in Austin MSA"
    ]
  }
}